Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation.
Identifieur interne : 000398 ( Main/Exploration ); précédent : 000397; suivant : 000399Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation.
Auteurs : Bradley A. Maron ; Mark T. Gladwin ; Sebastien Bonnet ; Vinicio De Jesus Perez ; Sarah M. Perman ; Paul B. Yu ; Fumito IchinoseSource :
- Journal of the American Heart Association [ 2047-9980 ] ; 2020.
Descripteurs français
- KwdFr :
- Antiviraux (usage thérapeutique), Appréciation des risques (MeSH), Betacoronavirus (pathogénicité), Exposition professionnelle (effets indésirables), Exposition professionnelle (prévention et contrôle), Facteurs de risque (MeSH), Humains (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (thérapie), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (transmission), Infections à coronavirus (virologie), Interactions hôte-microbes (MeSH), Isolement du patient (MeSH), Pandémies (MeSH), Pneumopathie virale (diagnostic), Pneumopathie virale (thérapie), Pneumopathie virale (transmission), Pneumopathie virale (virologie), Poumon (anatomopathologie), Poumon (physiopathologie), Poumon (virologie), Résultat thérapeutique (MeSH), Santé au travail (MeSH), Soins de réanimation (méthodes), Sécurité des patients (MeSH), Thérapie respiratoire (MeSH), Transmission de maladie infectieuse du patient au professionnel de santé (prévention et contrôle), Virulence (MeSH).
- MESH :
- anatomopathologie : Poumon.
- diagnostic : Infections à coronavirus, Pneumopathie virale.
- effets indésirables : Exposition professionnelle.
- méthodes : Soins de réanimation.
- pathogénicité : Betacoronavirus.
- physiopathologie : Poumon.
- prévention et contrôle : Exposition professionnelle, Transmission de maladie infectieuse du patient au professionnel de santé.
- thérapie : Infections à coronavirus, Pneumopathie virale.
- traitement médicamenteux : Infections à coronavirus.
- usage thérapeutique : Antiviraux, Infections à coronavirus, Pneumopathie virale.
- virologie : Infections à coronavirus, Pneumopathie virale, Poumon.
- Appréciation des risques, Facteurs de risque, Humains, Interactions hôte-microbes, Isolement du patient, Pandémies, Résultat thérapeutique, Santé au travail, Sécurité des patients, Thérapie respiratoire, Virulence.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Betacoronavirus (pathogenicity), COVID-19 (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Coronavirus Infections (therapy), Coronavirus Infections (transmission), Coronavirus Infections (virology), Critical Care (methods), Host Microbial Interactions (MeSH), Humans (MeSH), Infectious Disease Transmission, Patient-to-Professional (prevention & control), Lung (pathology), Lung (physiopathology), Lung (virology), Occupational Exposure (adverse effects), Occupational Exposure (prevention & control), Occupational Health (MeSH), Pandemics (MeSH), Patient Isolation (MeSH), Patient Safety (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (therapy), Pneumonia, Viral (transmission), Pneumonia, Viral (virology), Respiratory Therapy (MeSH), Risk Assessment (MeSH), Risk Factors (MeSH), SARS-CoV-2 (MeSH), Treatment Outcome (MeSH), Virulence (MeSH).
- MESH :
- chemical , therapeutic use : Antiviral Agents.
- adverse effects : Occupational Exposure.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections.
- methods : Critical Care.
- pathogenicity : Betacoronavirus.
- pathology : Lung.
- physiopathology : Lung.
- prevention & control : Infectious Disease Transmission, Patient-to-Professional, Occupational Exposure.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- virology : Coronavirus Infections, Lung, Pneumonia, Viral.
- COVID-19, Host Microbial Interactions, Humans, Occupational Health, Pandemics, Patient Isolation, Patient Safety, Respiratory Therapy, Risk Assessment, Risk Factors, SARS-CoV-2, Treatment Outcome, Virulence.
DOI: 10.1161/JAHA.120.017111
PubMed: 32552164
PubMed Central: PMC7660729
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation.</title>
<author><name sortKey="Maron, Bradley A" sort="Maron, Bradley A" uniqKey="Maron B" first="Bradley A" last="Maron">Bradley A. Maron</name>
<affiliation><nlm:affiliation>Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</nlm:affiliation>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Gladwin, Mark T" sort="Gladwin, Mark T" uniqKey="Gladwin M" first="Mark T" last="Gladwin">Mark T. Gladwin</name>
<affiliation><nlm:affiliation>Brigham and Women's Hospital and Harvard Medical School Division of Pulmonary, Allergy, and Critical Care and Heart, Lung, Blood, and Vascular Medicine Institute University of Pittsburgh PA.</nlm:affiliation>
<wicri:noCountry code="subField">and Vascular Medicine Institute University of Pittsburgh PA</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bonnet, Sebastien" sort="Bonnet, Sebastien" uniqKey="Bonnet S" first="Sebastien" last="Bonnet">Sebastien Bonnet</name>
<affiliation><nlm:affiliation>Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</nlm:affiliation>
<wicri:noCountry code="no comma">Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</wicri:noCountry>
<wicri:noCountry code="no comma">Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="De Jesus Perez, Vinicio" sort="De Jesus Perez, Vinicio" uniqKey="De Jesus Perez V" first="Vinicio" last="De Jesus Perez">Vinicio De Jesus Perez</name>
<affiliation><nlm:affiliation>Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</nlm:affiliation>
<wicri:noCountry code="no comma">Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</wicri:noCountry>
<wicri:noCountry code="no comma">Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Perman, Sarah M" sort="Perman, Sarah M" uniqKey="Perman S" first="Sarah M" last="Perman">Sarah M. Perman</name>
<affiliation><nlm:affiliation>Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</nlm:affiliation>
<wicri:noCountry code="no comma">Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</wicri:noCountry>
<wicri:noCountry code="no comma">Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Yu, Paul B" sort="Yu, Paul B" uniqKey="Yu P" first="Paul B" last="Yu">Paul B. Yu</name>
<affiliation><nlm:affiliation>Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</nlm:affiliation>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ichinose, Fumito" sort="Ichinose, Fumito" uniqKey="Ichinose F" first="Fumito" last="Ichinose">Fumito Ichinose</name>
<affiliation><nlm:affiliation>Anesthesia Center for Critical Care Research Department of Anesthesia Critical Care, and Pain Medicine Massachusetts General Hospital Harvard Medical School Boston MA.</nlm:affiliation>
<wicri:noCountry code="subField">and Pain Medicine Massachusetts General Hospital Harvard Medical School Boston MA</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32552164</idno>
<idno type="pmid">32552164</idno>
<idno type="doi">10.1161/JAHA.120.017111</idno>
<idno type="pmc">PMC7660729</idno>
<idno type="wicri:Area/Main/Corpus">000587</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000587</idno>
<idno type="wicri:Area/Main/Curation">000587</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000587</idno>
<idno type="wicri:Area/Main/Exploration">000587</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation.</title>
<author><name sortKey="Maron, Bradley A" sort="Maron, Bradley A" uniqKey="Maron B" first="Bradley A" last="Maron">Bradley A. Maron</name>
<affiliation><nlm:affiliation>Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</nlm:affiliation>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Gladwin, Mark T" sort="Gladwin, Mark T" uniqKey="Gladwin M" first="Mark T" last="Gladwin">Mark T. Gladwin</name>
<affiliation><nlm:affiliation>Brigham and Women's Hospital and Harvard Medical School Division of Pulmonary, Allergy, and Critical Care and Heart, Lung, Blood, and Vascular Medicine Institute University of Pittsburgh PA.</nlm:affiliation>
<wicri:noCountry code="subField">and Vascular Medicine Institute University of Pittsburgh PA</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bonnet, Sebastien" sort="Bonnet, Sebastien" uniqKey="Bonnet S" first="Sebastien" last="Bonnet">Sebastien Bonnet</name>
<affiliation><nlm:affiliation>Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</nlm:affiliation>
<wicri:noCountry code="no comma">Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</wicri:noCountry>
<wicri:noCountry code="no comma">Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="De Jesus Perez, Vinicio" sort="De Jesus Perez, Vinicio" uniqKey="De Jesus Perez V" first="Vinicio" last="De Jesus Perez">Vinicio De Jesus Perez</name>
<affiliation><nlm:affiliation>Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</nlm:affiliation>
<wicri:noCountry code="no comma">Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</wicri:noCountry>
<wicri:noCountry code="no comma">Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Perman, Sarah M" sort="Perman, Sarah M" uniqKey="Perman S" first="Sarah M" last="Perman">Sarah M. Perman</name>
<affiliation><nlm:affiliation>Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</nlm:affiliation>
<wicri:noCountry code="no comma">Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</wicri:noCountry>
<wicri:noCountry code="no comma">Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Yu, Paul B" sort="Yu, Paul B" uniqKey="Yu P" first="Paul B" last="Yu">Paul B. Yu</name>
<affiliation><nlm:affiliation>Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</nlm:affiliation>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
<wicri:noCountry code="no comma">Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ichinose, Fumito" sort="Ichinose, Fumito" uniqKey="Ichinose F" first="Fumito" last="Ichinose">Fumito Ichinose</name>
<affiliation><nlm:affiliation>Anesthesia Center for Critical Care Research Department of Anesthesia Critical Care, and Pain Medicine Massachusetts General Hospital Harvard Medical School Boston MA.</nlm:affiliation>
<wicri:noCountry code="subField">and Pain Medicine Massachusetts General Hospital Harvard Medical School Boston MA</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the American Heart Association</title>
<idno type="eISSN">2047-9980</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Coronavirus Infections (virology)</term>
<term>Critical Care (methods)</term>
<term>Host Microbial Interactions (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infectious Disease Transmission, Patient-to-Professional (prevention & control)</term>
<term>Lung (pathology)</term>
<term>Lung (physiopathology)</term>
<term>Lung (virology)</term>
<term>Occupational Exposure (adverse effects)</term>
<term>Occupational Exposure (prevention & control)</term>
<term>Occupational Health (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Patient Isolation (MeSH)</term>
<term>Patient Safety (MeSH)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Respiratory Therapy (MeSH)</term>
<term>Risk Assessment (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Virulence (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term>
<term>Appréciation des risques (MeSH)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Exposition professionnelle (effets indésirables)</term>
<term>Exposition professionnelle (prévention et contrôle)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (transmission)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Interactions hôte-microbes (MeSH)</term>
<term>Isolement du patient (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Pneumopathie virale (transmission)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Poumon (anatomopathologie)</term>
<term>Poumon (physiopathologie)</term>
<term>Poumon (virologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Santé au travail (MeSH)</term>
<term>Soins de réanimation (méthodes)</term>
<term>Sécurité des patients (MeSH)</term>
<term>Thérapie respiratoire (MeSH)</term>
<term>Transmission de maladie infectieuse du patient au professionnel de santé (prévention et contrôle)</term>
<term>Virulence (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Occupational Exposure</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Exposition professionnelle</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Critical Care</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Soins de réanimation</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infectious Disease Transmission, Patient-to-Professional</term>
<term>Occupational Exposure</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Exposition professionnelle</term>
<term>Transmission de maladie infectieuse du patient au professionnel de santé</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Lung</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Host Microbial Interactions</term>
<term>Humans</term>
<term>Occupational Health</term>
<term>Pandemics</term>
<term>Patient Isolation</term>
<term>Patient Safety</term>
<term>Respiratory Therapy</term>
<term>Risk Assessment</term>
<term>Risk Factors</term>
<term>SARS-CoV-2</term>
<term>Treatment Outcome</term>
<term>Virulence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Appréciation des risques</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Interactions hôte-microbes</term>
<term>Isolement du patient</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
<term>Santé au travail</term>
<term>Sécurité des patients</term>
<term>Thérapie respiratoire</term>
<term>Virulence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32552164</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>14</Issue>
<PubDate><Year>2020</Year>
<Month>07</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Journal of the American Heart Association</Title>
<ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation>
</Journal>
<ArticleTitle>Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation.</ArticleTitle>
<Pagination><MedlinePgn>e017111</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.120.017111</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maron</LastName>
<ForeName>Bradley A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gladwin</LastName>
<ForeName>Mark T</ForeName>
<Initials>MT</Initials>
<AffiliationInfo><Affiliation>Brigham and Women's Hospital and Harvard Medical School Division of Pulmonary, Allergy, and Critical Care and Heart, Lung, Blood, and Vascular Medicine Institute University of Pittsburgh PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bonnet</LastName>
<ForeName>Sebastien</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Pulmonary Hypertension Research Group CRIUCPQ Laval University Quebec Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>De Jesus Perez</LastName>
<ForeName>Vinicio</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine Stanford University Stanford CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Perman</LastName>
<ForeName>Sarah M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo><Affiliation>Department of Emergency Medicine University of Colorado School of Medicine Denver CO.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yu</LastName>
<ForeName>Paul B</ForeName>
<Initials>PB</Initials>
<AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ichinose</LastName>
<ForeName>Fumito</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Anesthesia Center for Critical Care Research Department of Anesthesia Critical Care, and Pain Medicine Massachusetts General Hospital Harvard Medical School Boston MA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R21 NS116671</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL139613</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL139664</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 HL145420</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NS112373</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>K23 HL138164</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U54 HL119145</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P01 HL103455</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL125886</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL134776</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL153502</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL098032</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Am Heart Assoc</MedlineTA>
<NlmUniqueID>101580524</NlmUniqueID>
<ISSNLinking>2047-9980</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="N">Host Microbial Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017758" MajorTopicYN="N">Infectious Disease Transmission, Patient-to-Professional</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016273" MajorTopicYN="N">Occupational Exposure</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016272" MajorTopicYN="N">Occupational Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010356" MajorTopicYN="N">Patient Isolation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012138" MajorTopicYN="N">Respiratory Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID‐19</Keyword>
<Keyword MajorTopicYN="Y">pulmonary heart disease</Keyword>
<Keyword MajorTopicYN="Y">shock</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32552164</ArticleId>
<ArticleId IdType="doi">10.1161/JAHA.120.017111</ArticleId>
<ArticleId IdType="pmc">PMC7660729</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):819-824</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32219357</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Heart J. 2020 Mar 16;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32176300</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Oct 8;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32445440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jul 30;383(5):496-498</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32348640</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care Med. 2020 Jun;48(6):e440-e469</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32224769</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32220112</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2020 Jun 16;141(24):1948-1950</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2441-2448</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32356628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32169400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2020 May 21;55(5):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32341111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):811-818</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32219356</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):751-753</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32219362</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1463-1471</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32387246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Jun;8(6):e44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32325016</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2372-2374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302078</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Aug 18;173(4):268-277</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32374815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Heart Assoc. 2020 Jul 21;9(14):e017111</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32552164</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):802-810</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32211816</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 26;368:m1091</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32217556</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32348678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 21;382(21):e70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32374956</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2020 Jun 23;141(25):e933-e943</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32270695</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Am Thorac Soc. 2020 Sep;17(9):1161-1163</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32396457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):456-460</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171190</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 14;382(20):1957-1958</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32243118</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Med. 2017 Feb;130(2):207-213</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27984004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 21;382(21):2012-2022</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32227758</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am Heart J. 2020 Jun;224:57-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32305724</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2020 Apr 30;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32359410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circ Res. 2020 Jun 5;126(12):1671-1681</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302265</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 12;323(18):1773-1774</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32219367</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Bonnet, Sebastien" sort="Bonnet, Sebastien" uniqKey="Bonnet S" first="Sebastien" last="Bonnet">Sebastien Bonnet</name>
<name sortKey="De Jesus Perez, Vinicio" sort="De Jesus Perez, Vinicio" uniqKey="De Jesus Perez V" first="Vinicio" last="De Jesus Perez">Vinicio De Jesus Perez</name>
<name sortKey="Gladwin, Mark T" sort="Gladwin, Mark T" uniqKey="Gladwin M" first="Mark T" last="Gladwin">Mark T. Gladwin</name>
<name sortKey="Ichinose, Fumito" sort="Ichinose, Fumito" uniqKey="Ichinose F" first="Fumito" last="Ichinose">Fumito Ichinose</name>
<name sortKey="Maron, Bradley A" sort="Maron, Bradley A" uniqKey="Maron B" first="Bradley A" last="Maron">Bradley A. Maron</name>
<name sortKey="Perman, Sarah M" sort="Perman, Sarah M" uniqKey="Perman S" first="Sarah M" last="Perman">Sarah M. Perman</name>
<name sortKey="Yu, Paul B" sort="Yu, Paul B" uniqKey="Yu P" first="Paul B" last="Yu">Paul B. Yu</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000398 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000398 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidStanfordV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32552164 |texte= Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32552164" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidStanfordV1
This area was generated with Dilib version V0.6.38. |